Stephanie Markovina

1.9k total citations
57 papers, 845 citations indexed

About

Stephanie Markovina is a scholar working on Obstetrics and Gynecology, Oncology and Epidemiology. According to data from OpenAlex, Stephanie Markovina has authored 57 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Obstetrics and Gynecology, 21 papers in Oncology and 18 papers in Epidemiology. Recurrent topics in Stephanie Markovina's work include Endometrial and Cervical Cancer Treatments (29 papers), Cervical Cancer and HPV Research (16 papers) and Colorectal and Anal Carcinomas (11 papers). Stephanie Markovina is often cited by papers focused on Endometrial and Cervical Cancer Treatments (29 papers), Cervical Cancer and HPV Research (16 papers) and Colorectal and Anal Carcinomas (11 papers). Stephanie Markovina collaborates with scholars based in United States, Switzerland and United Kingdom. Stephanie Markovina's co-authors include Julie K. Schwarz, Perry W. Grigsby, T.A. DeWees, Barry A. Siegel, David G. Mutch, Alexander J. Lin, Farrokh Dehdashti, Matthew A. Powell, Premal H. Thaker and L. Stewart Massad and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Stephanie Markovina

53 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Markovina United States 17 286 263 252 214 158 57 845
Pamela Salman United States 11 253 0.9× 382 1.5× 646 2.6× 251 1.2× 190 1.2× 22 1.1k
Tilmann Lantzsch Germany 14 172 0.6× 144 0.5× 294 1.2× 157 0.7× 101 0.6× 26 819
Joerg Schwarz Germany 11 166 0.6× 140 0.5× 124 0.5× 190 0.9× 97 0.6× 13 592
M.L. Carcangiu Italy 15 143 0.5× 326 1.2× 390 1.5× 105 0.5× 117 0.7× 31 1.1k
Martin Heubner Germany 18 117 0.4× 247 0.9× 283 1.1× 64 0.3× 121 0.8× 47 869
Tadaaki Nishikawa Japan 14 81 0.3× 199 0.8× 300 1.2× 43 0.2× 215 1.4× 70 717
Darren Wheeler United States 15 285 1.0× 397 1.5× 262 1.0× 100 0.5× 164 1.0× 30 1.1k
Vincent Castonguay Canada 11 239 0.8× 415 1.6× 563 2.2× 250 1.2× 229 1.4× 43 1.0k
Anne‐Claire Hardy‐Bessard France 16 125 0.4× 129 0.5× 640 2.5× 62 0.3× 206 1.3× 59 961
Ghassan Allo Canada 16 107 0.4× 156 0.6× 194 0.8× 113 0.5× 172 1.1× 29 796

Countries citing papers authored by Stephanie Markovina

Since Specialization
Citations

This map shows the geographic impact of Stephanie Markovina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Markovina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Markovina more than expected).

Fields of papers citing papers by Stephanie Markovina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Markovina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Markovina. The network helps show where Stephanie Markovina may publish in the future.

Co-authorship network of co-authors of Stephanie Markovina

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Markovina. A scholar is included among the top collaborators of Stephanie Markovina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Markovina. Stephanie Markovina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Liyun, Songyan Wang, Lulu Sun, et al.. (2023). SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. Journal of Clinical Investigation. 133(15). 19 indexed citations
3.
Waters, Michael R., Matthew Inkman, J. Contreras, et al.. (2023). Genomic Characterization of Cervical Tumors Driven by Rare High-Risk HPV Subtypes Utilizing a Deep Learning Framework. International Journal of Radiation Oncology*Biology*Physics. 117(2). S131–S131. 1 indexed citations
4.
Bhatia, Rohini, et al.. (2023). SCCAg as a Biomarker of Advanced Stage and OS in Limited Resource Setting for Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S80–S81. 1 indexed citations
5.
Sun, Lulu, Molly C. Schroeder, Ian S. Hagemann, et al.. (2022). Expression of Potential Biomarker Targets by Immunohistochemistry in Cervical Carcinomas. International Journal of Gynecological Pathology. 41(6). 628–635. 3 indexed citations
6.
Muhammad, Naoshad, Jennifer Stanley, Kevin Cho, et al.. (2022). Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy. Cancer Research. 82(24). 4515–4527. 14 indexed citations
7.
Wang, Songyan, Cliff J. Luke, Stephen C. Pak, et al.. (2022). SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation. Communications Biology. 5(1). 46–46. 18 indexed citations
8.
Floberg, John M., Jin Zhang, Naoshad Muhammad, et al.. (2021). Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer. Clinical Cancer Research. 27(15). 4245–4255. 18 indexed citations
9.
Lin, Alexander J., Farrokh Dehdashti, L. Stewart Massad, et al.. (2021). Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response. Clinical Oncology. 33(5). 300–306. 9 indexed citations
10.
Henke, Lauren E., Jennifer Stanley, Clifford G. Robinson, et al.. (2021). Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer. International Journal of Radiation Oncology*Biology*Physics. 112(2). 379–389. 27 indexed citations
11.
Inkman, Matthew, Naoshad Muhammad, Christopher A. Miller, et al.. (2021). HPV transcript expression affects cervical cancer response to chemoradiation. JCI Insight. 6(16). 14 indexed citations
12.
Federico, Cinzia, Jennifer Sun, Barbara Muz, et al.. (2020). Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1483–1494. 48 indexed citations
13.
Wang, Songyan, et al.. (2020). Abstract 2426: SERPINB3 promotes radiation resistance in cervical cancer by inhibiting lysosome-mediated cell death. Cancer Research. 80(16_Supplement). 2426–2426.
14.
Lin, Alexander J., Pamela Samson, José Garcia-Ramirez, et al.. (2019). Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy. Brachytherapy. 18(3). 353–360. 6 indexed citations
15.
Lin, Alexander J., Si‐Rui Ma, Farrokh Dehdashti, et al.. (2019). Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma. International Journal of Gynecological Cancer. 29(3). 487–491. 15 indexed citations
16.
Markovina, Stephanie, Songyan Wang, Lauren E. Henke, et al.. (2017). Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. British Journal of Cancer. 118(1). 72–78. 55 indexed citations
17.
Markovina, Stephanie, Amit Roy, Sonya Aggarwal, et al.. (2017). Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(2). 417–426. 70 indexed citations
18.
Rao, Yuan James, R Chin, Caressa Hui, et al.. (2017). Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. Gynecologic Oncology. 146(3). 572–579. 30 indexed citations
19.
Badiyan, Shahed N., Stephanie Markovina, Joseph R. Simpson, et al.. (2014). Radiation Therapy Dose Escalation for Glioblastoma Multiforme in the Era of Temozolomide. International Journal of Radiation Oncology*Biology*Physics. 90(4). 877–885. 47 indexed citations
20.
Markovina, Stephanie, et al.. (2014). Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer. Practical Radiation Oncology. 4(6). 430–436. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Salman Breakdown of academic impact, for papers by Tilmann Lantzsch Breakdown of academic impact, for papers by Joerg Schwarz Breakdown of academic impact, for papers by M.L. Carcangiu Breakdown of academic impact, for papers by Martin Heubner Breakdown of academic impact, for papers by Tadaaki Nishikawa Breakdown of academic impact, for papers by Darren Wheeler Breakdown of academic impact, for papers by Vincent Castonguay Breakdown of academic impact, for papers by Anne‐Claire Hardy‐Bessard Breakdown of academic impact, for papers by Ghassan Allo
Rankless by CCL
2026